drugset / Trial / NCT01688921

Jet Injection for Influenza

NCT01688921 ↗

Phase 4 Completed 1250 enrolled PharmaJet, Inc.
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to determine if the administration of a seasonal flu vaccine using a PharmaJet's needle-free injection device (STRATIS) is equivalent to needle and syringe administration, as measured by laboratory tests of immune response.

Timeline

Start
2012-10
Primary completion
2013-03
Completion
2013-03

Outcome

Met primary endpoint

paper The immune response to Afluria when given by needle-free jet injector met the criteria for non-inferiority for all six coprimary endpoints. PMID 24881803 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Afluria Vaccine 0.5 ml Intramuscular

Indications